Penggunaan Steroid Sistemik pada Henoch Schonlein Purpura

Authors

  • Masyalia Hasna Taqiyyah Fakultas Kedokteran Universitas Trisakti, Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v48i11.154

Keywords:

purpura anafilaktoid, kortikosteroid

Abstract

Steroid umum digunakan pada HSP mengingat efek antiinflamasinya. Namun, di lain pihak beberapa kasus HSP dapat sembuh sendiri hanya dengan terapi simtomatik ataupun suportif. Penelitian terkini menunjukkan bahwa steroid hanya bermanfaat pada beberapa kasus HSP. Penggunaan steroid harus dipertimbangkan berdasarkan indikasi dan tidak untuk setiap kasus HSP.

Steroids are commonly used in all cases of HSP because of its anti-inflammatory effect. However, some HSP cases are self-limiting and only necessitate symptomatic or supportive therapy. Recent research has shown that steroids are beneficial in only a few cases of HSP. Steroid should be used as indicated and considered in every case of HSP.

Downloads

Download data is not yet available.

References

Roache-Robinson P, Hotwagner DT. Henoch Schönlein purpura. Treasure Island: StatPearls Publishing LLC; 2020.

Chen O, Zhu XB, Ren P, Wang YB, Sun RP, Wei DE. Henoch Schonlein purpura in children: Clinical analysis of 120 cases. Afr Health Sci. 2013;13:94–9

He X, Yu C, Zhao P, Ding Y, Liang X, Zhao Y, et al. The genetics of Henoch-Schonlein purpura: A systematic review and meta-analysis. Rheumatol Int. 2013;33:1387–95

Duvuru G, Stone JH. Imboden JB, Helmann DB, Stone JH. Henoch-Schonlein purpura. Current diagnosis and treatment rheumatology. 3rd ed. New York: McGraw-Hill Education; 2013 .p. 305-8

Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, et al. Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatr Nephrol. 2012;27(6):933-9.

Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C. Effects of corticosteroid on Henoch-Schönlein purpura: A systematic review. Pediatrics 2007;120(5):1079-87

Kurnia B. Henoch-Schonlein purpura in children: The role of corticosteroids. Maced J Med Sci. 2019;7(11):1812–4.

Nickavar A. Treatment of Henoch Schonlein nephritis; New trends. J Nephropathol. 2016;5(4):116-7.

Davin JC, Coppo R. Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch–Schönlein purpura nephritis. Pediatr Nephrol. 2013;28:1897–903

Gudjonsson JE, Elder JT. Henoch Schonlein purpura. In: Wolff K, Goldsmith LA, Katz SI. Fitzpatrick"s dermatology in general medicine. 9th Ed. McGraw Hill: New York; 2019 .p. 2007

Hwang HH, Lim IS, Choi BS, Yi DY. Analysis of seasonal tendencies in pediatric Henoch–Schönlein purpura and comparison with outbreak of infectious diseases. Medicine. 2018;97(36):1-9

Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schönlein purpura. Acta Derm Venereol. 2017;97(10):1160–6

Hochberg MC, Gravallese EM, Silman AJ, eds. Rheumatology.7th ed. Philadelphia, PA : Elsevier.2019: 1339-40.

Maritati F, Canzian A, Fenaroli P, Vaglio A. Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy. Presse Méd. 2020;49(3):1-6

Reamy BV, Williams PM, Lindsay TJ. Henoch-Schönlein purpura. Am Fam Physician. 2009;80(7):697-704

Reamy BV, Servey JT, Williams PM. Henoch-Schönlein purpura (IgA Vasculitis): Rapid evidence review. Am Fam Physician. 2020;102(4):229-33.

Ninchoji T, Kaito H, Nozu K, Hashimura Y, Kanda K., Kamioka I, et al. Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity. Pediatr Nephrol. 2011;26(4):563–9.

Hahn D, Hodson EM, Willis NS, Craig JC. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP). Cochrane Database Syst Rev. 2015;(8):CD005128.

Dudley J, Smith G, Llewelyn-Edwards A, Bayliss K, Pike K, Tizard J. Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein purpura (HSP). Arch Dis Child. 2013;98:756–63.

Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, et al. Early prednisone therapy in Henoch-Schönlein purpura: A randomized, double-blind, placebocontrolled trial. J Pediatr. 2006;149(2):241-7.

Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch–Shönlein purpura) in adults: Diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14(7):579–85.

Wang JJ, Xu Y, Liu FF, Wu Y, Samadli S, Wu YF, et al. Association of the infectious triggers with childhood Henoch–Schonlein purpura in Anhui province, China. J Infect Public Health. 2020;13:110-7

Downloads

Published

01-11-2021

How to Cite

Masyalia Hasna Taqiyyah. (2021). Penggunaan Steroid Sistemik pada Henoch Schonlein Purpura. Cermin Dunia Kedokteran, 48(11), 377–379. https://doi.org/10.55175/cdk.v48i11.154